Age of Aging 'Degenerative Brain Disease'Early detection is important
Sep 08, 2024
Due to the rapid aging, the incidence of degenerative brain diseases such as Parkinson's disease and Alzheimer's dementia is constantly increasing.
According to statistics from the Health Insurance Review and Assessment Service, the number of patients treated for Parkinson's disease in Korea increased by about 13% from 125,607 in 2019 to 140,2013 in 2023. During the same period, the number of dementia patients increased 22.3% from 551,845 to 674,963.
Professor Yun Nam-tae, head of the neurology department at Centum General Hospital, said "Degenerative brain disease progressively worsens, and when symptoms appear, it is often already advanced. As such, early detection and response greatly affect the quality of life of patients. He emphasized.
Therefore, using advanced diagnostic equipment such as PET-CT (positron emission tomography), the latest medical technology, to quickly respond with early detection and accurate diagnosis is very important for improving the quality of life of patients and their families.
Professor Yun Nam-tae said, `Parkinson's disease is caused by damage to dopamine neurons in the brain and causes symptoms such as 'shaking of hands, arms, legs, and face', movement slowdown (disability), and muscle stiffness. Alzheimer's dementia is caused by the accumulation of beta-amyloid proteins that damage brain cells, memory loss, cognitive and language skills, and personality and behavioral changes. He advised that once both diseases develop, slowing down the progression is the main goal of treatment, and it is important to diagnose them accurately in the early stages.
PET-CT tests play a very important role in early detection of these diseases. PET-CT is a highly precise diagnostic technique that visualizes the metabolic activity of the brain after injecting a small amount of radioactive isotopes into the body. This test detects abnormalities in nerve cells early, allowing Parkinson's disease and Alzheimer's dementia to be detected in the early stages.
In particular, Parkinson's disease can sensitively detect changes in the dopamine delivery system through PET-CT, so it can identify signs of the disease even before clinical symptoms appear. This makes it possible for patients to start treatment more quickly, which greatly helps to delay the deterioration of symptoms and maintain independence in daily life.
PET-CT also plays a key role in early diagnosis of Alzheimer's dementia. Through this test, the accumulation of beta-amyloid protein, one of the main causes of dementia, can be accurately visualized, enabling diagnosis before symptoms develop. Early detection of Alzheimer's dementia can slow the progression of the disease through appropriate medication and lifestyle improvements.
Professor Nam-tae Yoo said, `Early detection of degenerative brain disease is the key above all else, and it is recommended that patients and their families pay attention to even minor symptoms. In addition, by actively utilizing advanced checkups such as PET-CT, if you get tested early, you can detect and cope with it in advance, and it can greatly help maintain the patient's quality of life. "
According to statistics from the Health Insurance Review and Assessment Service, the number of patients treated for Parkinson's disease in Korea increased by about 13% from 125,607 in 2019 to 140,2013 in 2023. During the same period, the number of dementia patients increased 22.3% from 551,845 to 674,963.
Professor Yun Nam-tae, head of the neurology department at Centum General Hospital, said "Degenerative brain disease progressively worsens, and when symptoms appear, it is often already advanced. As such, early detection and response greatly affect the quality of life of patients. He emphasized.
Therefore, using advanced diagnostic equipment such as PET-CT (positron emission tomography), the latest medical technology, to quickly respond with early detection and accurate diagnosis is very important for improving the quality of life of patients and their families.
Professor Yun Nam-tae said, `Parkinson's disease is caused by damage to dopamine neurons in the brain and causes symptoms such as 'shaking of hands, arms, legs, and face', movement slowdown (disability), and muscle stiffness. Alzheimer's dementia is caused by the accumulation of beta-amyloid proteins that damage brain cells, memory loss, cognitive and language skills, and personality and behavioral changes. He advised that once both diseases develop, slowing down the progression is the main goal of treatment, and it is important to diagnose them accurately in the early stages.
PET-CT tests play a very important role in early detection of these diseases. PET-CT is a highly precise diagnostic technique that visualizes the metabolic activity of the brain after injecting a small amount of radioactive isotopes into the body. This test detects abnormalities in nerve cells early, allowing Parkinson's disease and Alzheimer's dementia to be detected in the early stages.
In particular, Parkinson's disease can sensitively detect changes in the dopamine delivery system through PET-CT, so it can identify signs of the disease even before clinical symptoms appear. This makes it possible for patients to start treatment more quickly, which greatly helps to delay the deterioration of symptoms and maintain independence in daily life.
PET-CT also plays a key role in early diagnosis of Alzheimer's dementia. Through this test, the accumulation of beta-amyloid protein, one of the main causes of dementia, can be accurately visualized, enabling diagnosis before symptoms develop. Early detection of Alzheimer's dementia can slow the progression of the disease through appropriate medication and lifestyle improvements.
Professor Nam-tae Yoo said, `Early detection of degenerative brain disease is the key above all else, and it is recommended that patients and their families pay attention to even minor symptoms. In addition, by actively utilizing advanced checkups such as PET-CT, if you get tested early, you can detect and cope with it in advance, and it can greatly help maintain the patient's quality of life. "
|
bellho@sportschosun.com
